Pascal Schneider

42.4k total citations · 19 hit papers
261 papers, 33.5k citations indexed

About

Pascal Schneider is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Pascal Schneider has authored 261 papers receiving a total of 33.5k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 123 papers in Immunology and 46 papers in Cancer Research. Recurrent topics in Pascal Schneider's work include Immune Cell Function and Interaction (56 papers), T-cell and B-cell Immunology (54 papers) and NF-κB Signaling Pathways (42 papers). Pascal Schneider is often cited by papers focused on Immune Cell Function and Interaction (56 papers), T-cell and B-cell Immunology (54 papers) and NF-κB Signaling Pathways (42 papers). Pascal Schneider collaborates with scholars based in Switzerland, United States and Germany. Pascal Schneider's co-authors include Jürg Tschopp, Fabienne Mackay, Jean-Luc Bodmer, Nils Holler, Margot Thome, Jeffrey L. Browning, Kay Hofmann, Lars E. French, Michael Hahne and Michael Schröter and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Pascal Schneider

257 papers receiving 32.9k citations

Hit Papers

Inhibition of death recep... 1996 2026 2006 2016 1997 2000 1999 1999 1997 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of death receptor signals by cellular FLIP
    1997 2.1k citations Pascal Schneider, Jürg Tschopp et al. profile →
  2. Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule
    2000 1.5k citations Pascal Schneider, Jürg Tschopp et al. profile →
  3. Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
    1999 1.2k citations Fabienne Mackay, Pascal Schneider et al. The Journal of Experimental Medicine profile →
  4. BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth
    1999 1.1k citations Pascal Schneider, Fabienne Mackay et al. The Journal of Experimental Medicine profile →
  5. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
    1997 1.1k citations Pascal Schneider, Edgar Meinl et al. profile →
  6. Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
    1996 1.1k citations Pascal Schneider et al. profile →
  7. IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
    2007 879 citations Pascal Schneider et al. profile →
  8. BAFF and APRIL: A Tutorial on B Cell Survival
    2003 780 citations Fabienne Mackay, Pascal Schneider et al. profile →
  9. BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF
    2001 751 citations Fang Qian, Martin Scott et al. profile →
  10. Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
    1998 736 citations Pascal Schneider et al. profile →
  11. Cracking the BAFF code
    2009 714 citations Fabienne Mackay, Pascal Schneider profile →
  12. The molecular architecture of the TNF superfamily
    2002 706 citations Pascal Schneider, Jürg Tschopp et al. profile →
  13. Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity
    1998 685 citations Pascal Schneider et al. The Journal of Experimental Medicine profile →
  14. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
    2002 681 citations Joanna R. Groom, Susan L. Kalled et al. Journal of Clinical Investigation profile →
  15. TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
    1997 605 citations Pascal Schneider, Jürg Tschopp et al. profile →
  16. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
    2002 601 citations Joanna R. Groom, Susan L. Kalled et al. Journal of Clinical Investigation profile →
  17. Baff Mediates Survival of Peripheral Immature B Lymphocytes
    2000 579 citations Marcel Batten, Joanna R. Groom et al. The Journal of Experimental Medicine profile →
  18. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
    2000 567 citations Pascal Schneider et al. profile →
  19. MyD88, an Adapter Protein Involved in Interleukin-1 Signaling
    1998 532 citations Pascal Schneider, Jürg Tschopp et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pascal Schneider 17.4k 14.9k 5.1k 4.8k 4.0k 261 33.5k
Francisco Sánchez‐Madrid 16.7k 1.0× 16.7k 1.1× 5.5k 1.1× 6.4k 1.3× 2.4k 0.6× 525 39.9k
Ghislain Opdenakker 9.4k 0.5× 9.5k 0.6× 8.6k 1.7× 8.0k 1.6× 2.5k 0.6× 512 30.1k
Dennis A. Carson 11.1k 0.6× 11.4k 0.8× 5.7k 1.1× 1.7k 0.4× 3.0k 0.8× 467 29.3k
Michael J. Lenardo 17.6k 1.0× 14.9k 1.0× 6.5k 1.3× 5.1k 1.1× 5.2k 1.3× 244 34.1k
Michael B. Brenner 27.8k 1.6× 9.9k 0.7× 5.7k 1.1× 1.5k 0.3× 5.1k 1.3× 295 40.8k
Owen N. Witte 9.5k 0.5× 14.8k 1.0× 7.3k 1.4× 2.7k 0.6× 1.4k 0.4× 349 35.9k
Brian Seed 11.8k 0.7× 17.8k 1.2× 5.0k 1.0× 3.8k 0.8× 2.3k 0.6× 155 33.2k
Andrew Wakeham 13.3k 0.8× 17.3k 1.2× 7.9k 1.5× 5.6k 1.2× 2.0k 0.5× 112 31.5k
Eugene C. Butcher 31.9k 1.8× 12.4k 0.8× 10.2k 2.0× 2.2k 0.4× 4.4k 1.1× 338 53.4k
Kenneth L. Rock 18.8k 1.1× 17.6k 1.2× 5.2k 1.0× 1.7k 0.3× 4.6k 1.1× 202 33.9k

Countries citing papers authored by Pascal Schneider

Since Specialization
Citations

This map shows the geographic impact of Pascal Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Schneider more than expected).

Fields of papers citing papers by Pascal Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Schneider. The network helps show where Pascal Schneider may publish in the future.

Co-authorship network of co-authors of Pascal Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Schneider. A scholar is included among the top collaborators of Pascal Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Schneider. Pascal Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peris, Leticia, Delphine Meffre, Benoît Manfroi, et al.. (2024). The inflammatory APRIL (a proliferation-inducing ligand) antagonizes chondroitin sulphate proteoglycans to promote axonal growth and myelination. Brain Communications. 7(1). fcae473–fcae473.
2.
Schuepbach‐Mallepell, Sonia, Laure Willen, Christine Kowalczyk‐Quintas, et al.. (2024). Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues. Proceedings of the National Academy of Sciences. 121(29). e2404309121–e2404309121. 11 indexed citations
3.
Felten, Renaud, Anne‐Perrine Foray, Pascal Schneider, et al.. (2024). Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren’s disease. RMD Open. 10(3). e004112–e004112. 2 indexed citations
4.
Fichtner, Miriam L., Heike Rübsamen, Michaela Smolle, et al.. (2023). Features of Isoforms of Human Soluble TACI. The Journal of Immunology. 211(2). 199–208. 1 indexed citations
5.
Heppelmann, Maike, Marion Hewicker‐Trautwein, Maren Hellige, et al.. (2023). A Missense Mutation in the Collagen Triple Helix of EDA Is Associated with X-Linked Recessive Hypohidrotic Ectodermal Dysplasia in Fleckvieh Cattle. Genes. 15(1). 8–8. 1 indexed citations
6.
Schneider, Pascal, et al.. (2023). Ein universeller, kontinuierlicher Assay für SAM‐abhängige Methyltransferasen. Angewandte Chemie. 135(51). 1 indexed citations
7.
Schneider, Pascal, et al.. (2022). Sialic acids on B cells are crucial for their survival and provide protection against apoptosis. Proceedings of the National Academy of Sciences. 119(25). e2201129119–e2201129119. 13 indexed citations
8.
Nuebling, Tina, Martin Hofmann, Ilona Hagelstein, et al.. (2018). The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia. Cancer Immunology Research. 6(2). 209–221. 46 indexed citations
9.
Chennupati, Vijaykumar, Diogo F. T. Veiga, Kendle M. Maslowski, et al.. (2018). Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation. Journal of Clinical Investigation. 128(4). 1597–1614. 18 indexed citations
10.
Rodríguez-Barbosa, José-Ignacio, M.C. Ferreras, Léo H. Bühler, et al.. (2018). Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation. mAbs. 10(7). 1–15. 3 indexed citations
11.
Jia, Shihai, et al.. (2017). Small-molecule Wnt agonists correct cleft palates in Pax9 mutant mice in utero. Development. 144(20). 3819–3828. 53 indexed citations
12.
Manfroi, Benoît, Thomas McKee, Sébastien P. Tabruyn, et al.. (2016). CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL. Cancer Research. 77(5). 1097–1107. 55 indexed citations
13.
Kowalczyk‐Quintas, Christine, Sonia Schuepbach‐Mallepell, Laure Willen, et al.. (2014). Pharmacological Stimulation of Edar Signaling in the Adult Enhances Sebaceous Gland Size and Function. Journal of Investigative Dermatology. 135(2). 359–368. 8 indexed citations
14.
Schmiedel, Benjamin Joachim, Tina Nuebling, Hans‐Georg Kopp, et al.. (2012). RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia. Cancer Research. 73(2). 683–694. 49 indexed citations
15.
Beleut, Manfred, Renuga Devi Rajaram, Marian Čaikovski, et al.. (2010). Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proceedings of the National Academy of Sciences. 107(7). 2989–2994. 239 indexed citations
16.
Belnoue, Elodie, Maria Pihlgren, Tracy L. McGaha, et al.. (2008). APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood. 111(5). 2755–2764. 266 indexed citations
17.
Pappu, Bhanu P., Anna Borodovsky, Timothy S. Zheng, et al.. (2008). TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. The Journal of Experimental Medicine. 205(5). 1049–1062. 177 indexed citations
18.
Brunetti, Craig R., Rajkumari Singh, Jing Qin, et al.. (2003). A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proceedings of the National Academy of Sciences. 100(8). 4831–4836. 49 indexed citations
19.
Groom, Joanna R., Susan L. Kalled, Anne H. Cutler, et al.. (2002). Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. Journal of Clinical Investigation. 109(1). 59–68. 63 indexed citations
20.
Batten, Marcel, Joanna R. Groom, Teresa G. Cachero, et al.. (2000). Baff Mediates Survival of Peripheral Immature B Lymphocytes. The Journal of Experimental Medicine. 192(10). 1453–1466. 579 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Sánchez‐Madrid Breakdown of academic impact, for papers by Ghislain Opdenakker Breakdown of academic impact, for papers by Dennis A. Carson Breakdown of academic impact, for papers by Michael J. Lenardo Breakdown of academic impact, for papers by Michael B. Brenner Breakdown of academic impact, for papers by Owen N. Witte Breakdown of academic impact, for papers by Brian Seed Breakdown of academic impact, for papers by Andrew Wakeham Breakdown of academic impact, for papers by Eugene C. Butcher Breakdown of academic impact, for papers by Kenneth L. Rock
Rankless by CCL
2026